Gainers
- Intelligent Bio Solutions INBS stock rose 8.6% to $2.14 during Friday's after-market session. The company's market cap stands at $4.9 million.
- MSP Recovery LIFW shares increased by 6.68% to $0.23. The company's market cap stands at $76.1 million.
- Mesoblast MESO stock increased by 5.0% to $4.2. The market value of their outstanding shares is at $683.4 million.
- Annexon ANNX stock rose 4.98% to $3.37. The market value of their outstanding shares is at $178.8 million.
- Matinas BioPharma Hldgs MTNB shares increased by 4.87% to $0.39. The market value of their outstanding shares is at $85.7 million.
- Renalytix RNLX stock increased by 4.72% to $3.1. The market value of their outstanding shares is at $146.9 million.
Losers
- OKYO Pharma OKYO shares declined by 29.6% to $1.55 during Friday's after-market session. This security traded at a volume of 249.0K shares come close, making up 245.0% of its average volume over the last 100 days. The company's market cap stands at $39.5 million.
- Science 37 Hldgs SNCE shares declined by 7.14% to $0.25. The market value of their outstanding shares is at $29.1 million.
- Impel Pharmaceuticals IMPL stock fell 6.21% to $1.36. The market value of their outstanding shares is at $32.2 million.
- OptiNose OPTN stock fell 5.99% to $1.1. The company's market cap stands at $123.1 million.
- eFFECTOR Therapeutics EFTR shares decreased by 5.21% to $0.77. The company's market cap stands at $47.5 million.
- Navidea Biopharmaceutical NAVB stock declined by 5.16% to $0.09. Navidea Biopharmaceutical's trading volume hit 2.9 million shares by close, accounting for 40.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $3.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in